We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DBD
2251
DELISTED
Diebold Nixdorf Incorporated
DBD
| $551K | ﹤0.01% |
221,418
+39,012
| +21% | +$140K |
|
|
EPZM
2252
DELISTED
Epizyme, Inc
EPZM
| $551K | ﹤0.01% |
89,394
+38,852
| +77% | +$297K |
|
|
ACBI
2253
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $551K | ﹤0.01% |
33,643
+11,098
| +49% | +$183K |
|
2254
Ducommun
DCO
$3.04B
| $549K | ﹤0.01% |
15,118
+4,511
| +43% | +$174K |
|
2255
Upland Software
UPLD
$12.6M
| $549K | ﹤0.01% |
2,021
+671
| +50% | +$201K |
|
|
CTLP
2256
DELISTED
Cantaloupe
CTLP
| $547K | ﹤0.01% |
140,601
+92,071
| +190% | +$483K |
|
2257
NRC Health Common Stock
NRC
$431M
| $546K | ﹤0.01% |
14,318
+4,849
| +51% | +$186K |
|
2258
RPC Inc
RES
$1.31B
| $546K | ﹤0.01% |
55,358
-1,671
| -3% | -$22.7K |
|
2259
York Water
YORW
$512M
| $545K | ﹤0.01% |
16,998
+5,432
| +47% | +$174K |
|
2260
iShares Russell 2000 Value ETF
IWN
$14.5B
| $543K | ﹤0.01% |
5,045
+1,388
| +38% | +$167K |
|
2261
RadNet
RDNT
$5.36B
| $541K | ﹤0.01% |
53,147
+16,935
| +47% | +$230K |
|
2262
Expro Ltd
XPRO
$1.91B
| $541K | ﹤0.01% |
17,271
+5,419
| +46% | +$235K |
|
|
GTHX
2263
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $541K | ﹤0.01% |
28,246
+9,772
| +53% | +$366K |
|
|
CTT
2264
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $539K | ﹤0.01% |
75,866
+21,025
| +38% | +$187K |
|
|
GLDD
2265
DELISTED
Great Lakes Dredge & Dock
GLDD
| $537K | ﹤0.01% |
81,097
+23,952
| +42% | +$156K |
|
2266
Vishay Precision Group
VPG
$906M
| $536K | ﹤0.01% |
17,723
+4,458
| +34% | +$146K |
|
2267
Citizens
CIA
$231M
| $535K | ﹤0.01% |
71,126
+20,865
| +42% | +$164K |
|
2268
Tejon Ranch
TRC
$444M
| $535K | ﹤0.01% |
32,254
+9,080
| +39% | +$169K |
|
|
PS
2269
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $535K | ﹤0.01% |
22,709
+5,529
| +32% | +$127K |
|
2270
Old Second Bancorp
OSBC
$1.31B
| $534K | ﹤0.01% |
41,112
+12,325
| +43% | +$174K |
|
|
BELFB
2271
Bel Fuse Inc Class B
BELFB
$4.18B
| $533K | ﹤0.01% |
28,919
+4,835
| +20% | +$109K |
|
|
WRD
2272
DELISTED
WildHorse Resource Development
WRD
| $532K | ﹤0.01% |
37,733
+11,912
| +46% | +$235K |
|
2273
SIGA Technologies
SIGA
$224M
| $531K | ﹤0.01% |
67,189
+22,627
| +51% | +$129K |
|
2274
International Seaways
INSW
$4.61B
| $530K | ﹤0.01% |
31,479
+9,228
| +41% | +$178K |
|
2275
Bristow Group
VTOL
$1.33B
| $529K | ﹤0.01% |
30,276
+4,826
| +19% | +$103K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.